Teva to Buy Allergan Generics in $40.5 Billion Deal (NYSE: TEVA)

Teva to Buy Allergan Generics: Teva announced Monday it will buy Allergan Generics in a deal valued at $40.5 billion.

The move further cements Teva's position as the world's biggest seller of off-brand drugs, and it allows Allergan to focus on its higher-margin brand-name drugs.

Here's everything investors need to know about the deal now...

Tags: Allergan stock, NYSE: AGN, NYSE: TEVA, Teva Allergan, Teva Allergan deal, Teva and Allergan, Teva buys allergan, Teva stock, Teva to Buy...

What feeling does this article give you?

#hashtags to follow:

Teva [+]    Buy Allergan Generics [+]    Monday [+]    Allergan Generics [+]    Allergan [+]    Tags [+]    NYSE [+]    AGN [+]    TEVA [+]    Teva Allergan [+]   

More #news: